Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_assertion type Assertion NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_head.
- NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_assertion wasGeneratedBy ECO_0000203 NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_provenance.
- NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_assertion wasDerivedFrom befree-20140225 NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_provenance.
- NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_assertion SIO_000772 14965242 NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_provenance.
- NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_assertion evidence source_evidence_literature NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_provenance.
- NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_assertion description "[The 5-HT(3) receptor antagonists, via a central and / or peripheral action, have been shown to reduce secretion and motility in the gut and possess clinical utility in irritable bowel syndrome, and possibly other visceral pain disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_provenance.